STOCK TITAN

Sit holds 5,447,450 shares in Neuberger (NYSE: NHS) — 13.0%

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Neuberger High Yield Strategies Fund Inc. Schedule 13G discloses that Sit Investment Associates, Inc. and its subsidiary Sit Fixed Income Advisors II, LLC report shared voting and dispositive power over 5,447,450 shares of Common Stock (CUSIP 64128C106), representing 13.0% of the class. The filing bases percentages on 41,855,793 shares outstanding as of October 31, 2025 and notes adjustment for a rights offering dated April 15, 2026. The advisers state the shares are held in client accounts and disclaim beneficial ownership pursuant to Rule 13d-4.

Positive

  • None.

Negative

  • None.

Insights

SIA/SFI report shared control of 5,447,450 shares (13.0%) of Neuberger NHS.

The filing shows Sit Investment Associates and its subsidiary exercise shared voting and dispositive power over those shares held in managed client accounts; they disclaim beneficial ownership under Rule 13d-4. Ownership percentages use 41,855,793 shares outstanding as of October 31, 2025 and reflect a rights offering adjustment dated April 15, 2026.

Impact depends on client trading decisions; the filing is an ownership disclosure under Schedule 13G rather than an active market-moving transaction. Subsequent Form 13D or trading disclosures would change the record.

Shared voting/dispositive power 5,447,450 shares Reported holding by SIA/SFI
Percent of class 13.0% Based on shares outstanding as of October 31, 2025
Shares outstanding 41,855,793 shares As of October 31, 2025 (per Form N-CSR)
CUSIP 64128C106 Neuberger High Yield Strategies Fund Inc. Common Stock
Rights offering adjustment date April 15, 2026 Adjustment to outstanding share base
Schedule 13G regulatory
"Item 1. (a) Name of issuer: Neuberger High Yield Strategies Fund Inc."
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
Rule 13d-4 regulatory
"Pursuant to Rule 13d-4 of the Securities Exchange Act of 1934"
beneficial ownership financial
"SIA and SFI disclaim beneficial ownership of such securities"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.





64128C106

(CUSIP Number)
04/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Sit Investment Associates, Inc.
Signature:/s/ Paul E. Rasmussen
Name/Title:Paul Rasmussen / Vice President
Date:05/05/2026
Sit Fixed Income Advisors II, LLC
Signature:/s/ Paul E. Rasmussen
Name/Title:Paul Rasmussen / Vice President
Date:05/05/2026
Exhibit Information

Exhibit A - Joint Filing Agreement

FAQ

What stake does Sit report in Neuberger High Yield Strategies Fund (NHS)?

Sit reports 5,447,450 shares, equal to 13.0% of the class. Percentages are based on 41,855,793 shares outstanding as of October 31, 2025, adjusted for a rights offering dated April 15, 2026.

Does Sit claim beneficial ownership of the reported NHS shares?

No. Sit states the shares are owned by client accounts and, pursuant to Rule 13d-4, the advisers disclaim beneficial ownership while reporting shared voting and dispositive power over the 5,447,450 shares.

Which entities filed the Schedule 13G for NHS?

The filing lists Sit Investment Associates, Inc. and its subsidiary Sit Fixed Income Advisors II, LLC. Addresses and citizenships are provided: Minnesota corporation and Delaware LLC respectively.

What outstanding share count does the filing use to calculate the percent?

The filing uses 41,855,793 shares outstanding as of October 31, 2025. That figure was reported on Form N-CSR and adjusted for the issuer's rights offering on April 15, 2026.